Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

  1. Genovese, M.C.
  2. McKay, J.D.
  3. Nasonov, E.L.
  4. Mysler, E.F.
  5. Da Silva, N.A.
  6. Alecock, E.
  7. Woodworth, T.
  8. Gomez-Reino, J.J.
Revista:
Arthritis and Rheumatism

ISSN: 0004-3591

Ano de publicación: 2008

Volume: 58

Número: 10

Páxinas: 2968-2980

Tipo: Artigo

DOI: 10.1002/ART.23940 GOOGLE SCHOLAR

Obxectivos de Desenvolvemento Sustentable